Clinical Trial Update: Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With Osteopenia [NA]

View source ↗

Summary

A completed clinical trial update reports simplification of antiretroviral therapy from regimens containing tenofovir disoproxil fumarate plus lamivudine or emt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Osteopenia

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)
• Emtricitabine (Emtricitabine)
• Lamivudine (lamivudine)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Judit Pich | Conditions: Human Immunodeficiency Virus | NA | Status: COMPLETED | Results posted: 2025-07-02